Bio-Rad Labs Inc. A buy Royal Bank of Canada
Start price
04.08.23
/
50%
€363.40
Target price
04.08.24
€474.64
Performance (%)
-17.06%
End price
05.08.24
€301.40
Summary
This prediction ended on 05.08.24 with a price of €301.40. The price of Bio-Rad Labs Inc. A has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.06%. Royal_Bank_of_Canada has a follow-up prediction for Bio-Rad Labs Inc. A where he still thinks Bio-Rad Labs Inc. A is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Bio-Rad Labs Inc. A | -2.555% | -2.555% | -11.088% |
iShares Core DAX® | -3.429% | 3.133% | 15.455% |
iShares Nasdaq 100 | -6.121% | -1.433% | 16.794% |
iShares Nikkei 225® | -7.364% | 1.018% | 8.293% |
iShares S&P 500 | -4.366% | 0.247% | 18.541% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank of Canada from $522.00 to $524.00. They now have an "outperform" rating on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€445.58
16.02.25
16.02.25
-5.91%
06.09.24
06.09.24
Stopped prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€292.30
16.08.24
16.08.24
€364.63
16.08.25
16.08.25
1.37%
06.09.24
06.09.24
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€307.80
02.08.24
02.08.24
€367.36
02.08.25
02.08.25
-3.35%
06.09.24
06.09.24